首页> 外文期刊>The biochemical journal >The mosaic receptor sorLA/LR11 binds components of the plasminogen-activating system and platelet-derived growth factor-BB similarly to LRP1 (low-density lipoprotein receptor-related protein), but mediates slow internalization of bound ligand
【24h】

The mosaic receptor sorLA/LR11 binds components of the plasminogen-activating system and platelet-derived growth factor-BB similarly to LRP1 (low-density lipoprotein receptor-related protein), but mediates slow internalization of bound ligand

机译:镶嵌受体sorLA / LR11与LRP1(低密度脂蛋白受体相关蛋白)相似,结合纤溶酶原激活系统和血小板衍生的生长因子BB的成分,但介导结合配体的缓慢内在化

获取原文
获取外文期刊封面目录资料

摘要

pThe type-1 receptor sorLA/LR11, a member of the Vps10p-domain receptor family that also contains domains characterizing members of the LDL (low-density lipoprotein) receptor family, has been shown to induce increased uPAR (urokinase receptor) expression as well as enhanced migration and invasion activities in smooth muscle cells in the presence of PDGF-BB (platelet-derived growth factor-BB). Here we show that sorLA interacts with both components of the plasminogen activating system and PDGF-BB similarly to LRP1 (LDL receptor-related protein/αsub2/sub-macroglobulin receptor), which is an important clearance receptor with established functions in controlling uPAR expression as well as PDGF-BB signalling. In contrast with LRP1, sorLA does not interact with αsub2/sub-macroglobulin, which is a binding protein for several growth factors, including PDGF-BB. By using LRP1-deficient cells transfected with sorLA, we demonstrate that sorLA-bound ligand is internalized at a much lower rate than LRP1-bound ligand, and that sorLA is inefficient in regulating cell surface uPAR expression, which depends on rapid internalization of the ternary complex between urokinase-type plasminogen activator, its type-1 inhibitor, and uPAR. Thus, although overlapping with regard to binding profiles, sorLA is substantially less efficient as a clearance receptor than LRP1. We propose that sorLA can divert ligands away from LRP1 and thereby inhibit both their clearance and signalling events mediated by LRP1./p
机译:> 1型受体sorLA / LR11是Vps10p结构域受体家族的成员,其中也包含表征LDL(低密度脂蛋白)受体家族成员的结构域,已被证明可诱导uPAR(尿激酶受体)增加。 PDGF-BB(血小板衍生的生长因子-BB)存在时,在平滑肌细胞中的表达以及增强的迁移和侵袭活性。在这里,我们发现sorLA与纤溶酶原激活系统和PDGF-BB的两个组件都相互作用,类似于LRP1(LDL受体相关蛋白/α 2 -巨球蛋白受体),它是已建立的重要清除受体在控制uPAR表达以及PDGF-BB信号转导中发挥功能。与LRP1相比,sorLA不与α 2 -巨球蛋白相互作用,α 2 -巨球蛋白是多种生长因子(包括PDGF-BB)的结合蛋白。通过使用转染了sorLA的LRP1缺陷型细胞,我们证明了sorLA结合的配体的内化速率远低于LRP1结合的配体,并且sorLA在调节细胞表面uPAR表达方面效率低下,这取决于三元的快速内在化尿激酶型纤溶酶原激活剂,其1型抑制剂和uPAR之间的复合物。因此,尽管在结合特征上有重叠,但作为清除受体,sorLA的效率远不如LRP1。我们认为,sorLA可以使配体脱离LRP1,从而抑制其清除和由LRP1介导的信号转导事件。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号